What Researchers Did
The researchers reviewed hospital records of people with calciphylaxis, a painful skin and wound condition linked to kidney failure, who were referred for hyperbaric oxygen therapy (HBOT), and looked at wound healing and survival afterward.
What They Found
This retrospective review of 46 patients with calciphylaxis and kidney failure found that, among the 34 who received a full course of HBOT, 58% showed improvement in their wound scores, and more than half of those patients had complete healing. The other 12 patients were judged unsuitable for treatment or could not tolerate it, and they were palliated. The remaining patients who completed HBOT did not benefit and had a very poor prognosis. Patients who benefited survived an average of more than 3 years. Diabetes was the only factor significantly linked to better wound healing and survival. The study had no comparison group, so it cannot show that HBOT caused the healing.
What This Means for Canadian Patients
For people with calciphylaxis and end-stage kidney disease, this review suggests that some patients who completed HBOT had wound improvement, but a large share did not benefit, and the outlook for those patients was very poor. The authors describe their findings as suggesting a possible role for HBOT, not as proof. Decisions about treatment belong with the patient's kidney and wound care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective review of records from one institution with no comparison group, so the results show an association only and cannot confirm that HBOT caused the wound healing or longer survival.